Articles related to RESEARCH & CLINICAL TRIALS

Multiple post-licensure studies have failed to demonstrate ticagrelor’s superiority over clopidogrel, prompting leading cardiologists to call for guideline reappraisal.

In a significant advancement for knee osteoarthritis treatment, LEVI-04 demonstrated pain reduction in more than 50% of treated patients, with effects lasting through 20 weeks of study.

Nearly half of clinical trial participants achieved such significant improvements that their OSA symptoms were effectively resolved, marking a significant advancement in treating this complex disorder.

T cell activation by dietary proteins provides a previously unknown mechanism for tumor suppression in the small intestine, with significant implications for clinical nutrition protocols.

Combined omalizumab-OIT therapy demonstrated an impressive 50-percentage-point advantage over placebo in food challenge success rates for children with multiple food allergies.

A longitudinal study demonstrates that early peanut introduction can reduce allergy risk by 81%, with protection persisting through early adolescence despite varying consumption patterns.